0
The Functional Neuroanatomy of the Placebo Effect
Helen S. Mayberg, M.D., F.R.C.P.C.; J. Arturo Silva, M.D.; Steven K. Brannan, M.D.; Janet L. Tekell, M.D.; Roderick K. Mahurin, Ph.D.; Scott McGinnis, B.S.; Paul A. Jerabek, Ph.D.
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer’s Disease Treatment Studies
Gene E. Alexander, Ph.D.; Kewei Chen, Ph.D.; Pietro Pietrini, M.D., Ph.D.; Stanley I. Rapoport, M.D.; Eric M. Reiman, M.D.
Relationships Among the Metabolic Patterns That Correlate With Mnemonic, Visuospatial, and Mood Symptoms in Parkinson’s Disease
Marc J. Mentis, M.D.; Anthony R. McIntosh, Ph.D.; Kenneth Perrine, Ph.D.; Vijay Dhawan, Ph.D.; Brian Berlin, B.A.; Andy Feigin, M.D.; Christine Edwards, M.A.; Paul Mattis, Ph.D.; David Eidelberg, M.D.
Fluorine Magnetic Resonance Spectroscopy Measurement of Brain Fluvoxamine and Fluoxetine in Pediatric Patients Treated for Pervasive Developmental Disorders
Wayne L. Strauss, M.D., Ph.D.; Alan S. Unis, M.D.; Charles Cowan, M.D.; Geraldine Dawson, Ph.D.; Stephen R. Dager, M.D.
PET Study of D1 Dopamine Receptor Binding in Neuroleptic-Naive Patients With Schizophrenia
Per Karlsson, M.D.; Lars Farde, M.D., Ph.D.; Christer Halldin, Ph.D.; Göran Sedvall, M.D., Ph.D.
PET Study of [18F]6-Fluoro-l-Dopa Uptake in Neuroleptic- and Mood-Stabilizer-Naive First-Episode Nonpsychotic Mania: Effects of Treatment With Divalproex Sodium
Lakshmi N. Yatham, M.B.B.S.; Peter F. Liddle, Ph.D., M.B.B.S.; I-Shin Shiah, M.D.; Raymond W. Lam, M.D.; Elton Ngan, M.D.; Gayle Scarrow, B.A.; Miguel Imperial, B.A.; Jon Stoessl, M.D.; Vesna Sossi, Ph.D.; Thomas J. Ruth, Ph.D.
Characterizing Affective Instability in Borderline Personality Disorder
Harold W. Koenigsberg, M.D.; Philip D. Harvey, Ph.D.; Vivian Mitropoulou, M.A.; James Schmeidler, Ph.D.; Antonia S. New, M.D.; Marianne Goodman, M.D.; Jeremy M. Silverman, Ph.D.; Michael Serby, M.D.; Frances Schopick, M.S.W.; Larry J. Siever, M.D.
Depressive and Anxiety Disorders in Women With HIV Infection
Mary F. Morrison, M.D.; John M. Petitto, M.D.; Thomas Ten Have, Ph.D.; David R. Gettes, B.S.; Margaret S. Chiappini, R.N., M.N., C.C.R.C.; Anita L. Weber, Ph.D.; Priscilla Brinker-Spence, B.S.; Russell M. Bauer, Ph.D.; Steven D. Douglas, M.D.; Dwight L. Evans, M.D.
A Genome-Wide Scan for Linkage to Chromosomal Regions in 382 Sibling Pairs With Schizophrenia or Schizoaffective Disorder
Lynn E. DeLisi, M.D.; Sarah H. Shaw, Ph.D.; Timothy J. Crow, M.B., Ph.D.; Gail Shields, M.D.; Angela B. Smith, M.S.; Veronica W. Larach, M.D.; Nigel Wellman, R.N.; Josephine Loftus, M.B.; Betsy Nanthakumar, Ph.D.; Kamran Razi, M.D.; John Stewart, R.N.; Margherita Comazzi, M.D.; Antonio Vita, M.D.; Thomas Heffner, Ph.D.; Robin Sherrington, Ph.D.
Uncinate Fasciculus Findings in Schizophrenia: A Magnetic Resonance Diffusion Tensor Imaging Study
Marek Kubicki, M.D., Ph.D.; Carl-Fredrik Westin, Ph.D.; Stephan E. Maier, M.D., Ph.D.; Melissa Frumin, M.D.; Paul G. Nestor, Ph.D.; Dean F. Salisbury, Ph.D.; Ron Kikinis, M.D.; Ferenc A. Jolesz, M.D.; Robert W. McCarley, M.D.; Martha E. Shenton, Ph.D.
Estimated Neuronal Populations and Volumes of the Hippocampus and Its Subfields in Schizophrenia
Mary A. Walker; J. Robin Highley, D.Phil.; Margaret M. Esiri, F.R.C.Path.; Brendan McDonald, M.R.C.Path.; Helen C. Roberts, B.Sc.; Suzanne P. Evans, Ph.D.; Timothy J. Crow, F.R.C.Psych.
Supplementing Clinic-Based Skills Training With Manual-Based Community Support Sessions: Effects on Social Adjustment of Patients With Schizophrenia
Shirley M. Glynn, Ph.D.; Stephen R. Marder, M.D.; Robert P. Liberman, M.D.; Karen Blair, M.S.; William C. Wirshing, M.D.; Donna A. Wirshing, M.D.; Doreen Ross; Jim Mintz, Ph.D.
Test-Retest Stability of the Repeatable Battery for the Assessment of Neuropsychological Status in Schizophrenia
Christopher M. Wilk, M.A.; James M. Gold, Ph.D.; John J. Bartko, Ph.D.; Faith Dickerson, Ph.D.; Wayne S. Fenton, M.D.; Michael Knable, D.O.; Christopher Randolph, Ph.D.; Robert W. Buchanan, M.D.
Dropping Out of Mental Health Treatment: Patterns and Predictors Among Epidemiological Survey Respondents in the United States and Ontario
Mark J. Edlund, M.D., Ph.D.; Philip S. Wang, M.D., Dr.P.H.; Patricia A. Berglund, M.B.A.; Stephen J. Katz, M.D., M.P.H.; Elizabeth Lin, Ph.D.; Ronald C. Kessler, Ph.D.
Comorbid Posttraumatic Stress Disorder: Impact on Treatment Outcome for Obsessive-Compulsive Disorder
Beth S. Gershuny, Ph.D.; Lee Baer, Ph.D.; Michael A. Jenike, M.D.; William E. Minichiello, Ed.D.; Sabine Wilhelm, Ph.D.
Psychiatric Disorders in Rescue Workers After the Oklahoma City Bombing
Carol S. North, M.D., M.P.E.; Laura Tivis, Ph.D.; J. Curtis McMillen, Ph.D.; Betty Pfefferbaum, M.D., J.D.; Edward L. Spitznagel, Ph.D.; Jann Cox, M.S.W.; Sara Nixon, Ph.D.; Kenneth P. Bunch, B.A.; Elizabeth M. Smith, Ph.D.
Mental Health Care Quality Under Managed Care in the United States: A View From the Health Employer Data and Information Set (HEDIS)
Benjamin G. Druss, M.D., M.P.H.; Carolyn L. Miller, M.P.H.; Robert A. Rosenheck, M.D.; Sarah C. Shih, M.P.H.; James E. Bost, Ph.D.
Prospective Diagnosis of the Initial Prodrome for Schizophrenia Based on the Structured Interview for Prodromal Syndromes: Preliminary Evidence of Interrater Reliability and Predictive Validity
Tandy J. Miller, Ph.D.; Thomas H. McGlashan, M.D.; Joanna Lifshey Rosen, Psy.D.; Lubna Somjee, Ph.D.; Philip J. Markovich, B.A.; Kelly Stein, Ph.D.; Scott W. Woods, M.D.
Shape Differences in the Corpus Callosum in First-Episode Schizophrenia and First-Episode Psychotic Affective Disorder
Melissa Frumin, M.D.; Polina Golland, Ph.D.; Ron Kikinis, M.D.; Yoshio Hirayasu, M.D., Ph.D.; Dean F. Salisbury, Ph.D.; John Hennen, Ph.D.; Chandlee C. Dickey, M.D.; Mark Anderson, M.S.; Ferenc A. Jolesz, M.D.; W. Eric L. Grimson, Ph.D.; Robert W. McCarley, M.D.; Martha E. Shenton, Ph.D.
Neurobiological Measures of Schizotypal Personality Disorder: Defining an Inhibitory Endophenotype?
Kristin S. Cadenhead, M.D.; Gregory A. Light, Ph.D.; Mark A. Geyer, Ph.D.; Jennifer E. McDowell, Ph.D.; David L. Braff, M.D.
Fluoxetine for OCD After Brain Injury
KATARINA STENGLER-WENZKE, M.D.; ULRICH MÜLLER, M.D.
Topiramate for Obstructive Sleep Apnea and Snoring
MARCUS VINICIUS KECHE WEBER, M.D.
Pulmonary Embolism and Severe Depression
DANILO ARNONE, M.D.; LARS HANSEN, M.D.; GWYN DAVIES, M.D.
Antituberculosis Agents and Carbamazepine
MONICA ZOLEZZI, B.PHARM., M.SC.
Cyproheptadine for Drug-Induced Sweating
ADAM KELLER ASHTON, M.D.; WENDY L. WEINSTEIN, M.D.
Light Therapy, Obesity, and Night-Eating Syndrome
SERGE FRIEDMAN, M.D.; CHRISTIAN EVEN, M.D.; ROLAND DARDENNES, M.D.; JULIEN DANIEL GUELFI, M.D.
Clozapine and Venous Thromboembolism
CINDY KORTEPETER, PHARM.D.; MIN CHEN, R.PH., M.S.; JAMES F. KNUDSEN, PH.D., M.D.; GREG M. DUBITSKY, M.D.; SYED R. AHMAD, M.D., M.P.H.; JULIE BEITZ, M.D.
Posttermination Boundary Issues
RICHARD S. EPSTEIN, M.D.
Drs. Malmquist and Notman Reply
CARL P. MALMQUIST, M.D., M.S.; MALKAH T. NOTMAN, M.D.
Posttermination Boundary Issues
THOMAS G. GUTHEIL, M.D.
The Mind-Body Problem
G. SCOTT WATERMAN, M.D.; ROBERT J. SCHWARTZ, PH.D.
The Mind-Body Problem
LOUIS S. BERGER, PH.D.
The Mind-Body Problem
DAVID H. BRENDEL, M.D., PH.D.
Dr. Kendler Replies
KENNETH KENDLER, M.D.
The Mind-Body Problem
DONALD MENDER, M.D.
Abuse, Dependence, or Withdrawal Associated With Tramadol
ALLEN BRINKER, M.D., M.S.; RENAN A. BONNEL, PHARM.D., M.P.H.; JULIE BEITZ, M.D.
Dr. Yates Replies
WILLIAM R. YATES, M.D.
The Human GenomeGene Silencing
Hari Manev, M.D., Ph.D.; Svetlana Dzitoyeva, Ph.D.; Nikola Dimitrijevic, M.D.
Ladislav Haškovec and 100 Years of Akathisia
Martin Brüne, M.D.; Perminder S. Sachdev, M.D., Ph.D, F.R.A.N.Z.C.P.